Skip to main content
Caplight Logo









Lymphatica Medtech SA

Lymphatica Medtech SA

Private
LausanneHealthcare & Life Scienceshttps://lymphaticamedtech.com/

Last Round

Series B

Oct 8, 2024

Total Funding Raised

$25.04M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Lymphatica Medtech SA is a medical device company that develops implantable systems for the treatment of chronic lymphedema.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

medical devicelymphedema treatmentimplantable devicelymphatic drainagemedtechminimally invasive surgeryhealth IoTangiologyclinical-stageimplantable pumpFDA breakthrough devicewearable medical devicesmart implantchronic disease managementbioelectronic medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lymphatica Medtech SA Comparables

Compare Lymphatica Medtech SA with similar companies based on industry and business-model similarity.

Lymphatica Medtech SA comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sub-Q Bionics
79%
Fibralign Corporation
77%
Koya Medical
66%

Lymphatica Medtech SA Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BOct 8, 2024
DebtJun 15, 2023
GrantApr 28, 2023
Series ADec 3, 2020
GrantApr 1, 2019
Accelerator
Dec 7, 2017

Key People

Founding team and executive leadership

Valentina Triacca

Co-founder & COO

Founding Team

Marco Pisano

Co-Founder & CEO

Founding Team

Lymphatica Medtech SA Investors

Notable investors and investment history

Lymphatica Medtech SA investors
InvestorRounds
European Innovation Council FundGrant
Foundation for Technological InnovationDebt
EIT HealthSeries A
Club degli InvestitoriSeries B
Panakès PartnersSeries B
High-Tech GründerfondsSeries B, Series A
Venture KickAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 16, 2026

    Grew 25% QoQ, from 16 to 20 employees.

  • Jun 18, 2026

    Monthly visitors grew 363% MoM, reaching 629.

Lymphatica Medtech SA Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lymphatica Medtech SA Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lymphatica Medtech SA's valuation, stock price, and market status.

Firmographic Details

HeadquartersLausanne
Employee Range20
Year Founded2017
Last FundingOct 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?